SCHEMBL7964130

SCHEMBL7964130

N#CC(=Cc1ccc(O)c(O)c1)S(=O)(=O)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 1.00
HPGD P15428 9/20 1.00
KDM4E B2RXH2 8/20 1.00
KMT2A Q03164 7/20 1.00
MEN1 O00255 6/20 1.00
PKM P14618 5/20 1.00
SMN1; SMN2 Q16637 5/20 1.00
HSD17B10 Q99714 5/20 1.00
ALOX15 P16050 4/20 1.00
ALOX12 P18054 4/20 1.00
TDP1 Q9NUW8 4/20 1.00
L3MBTL1 Q9Y468 3/20 1.00
POLB P06746 1/20 1.00
GAA P10253 1/20 1.00
ALPG P10696 1/20 1.00
EGFR P00533 8/20 0.68
ERBB2 P04626 5/20 0.53
MAPT P10636 5/20 0.51
TP53 P04637 4/20 0.51
CYP1A2 P05177 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964126 1.00 ALDH1A1 (1.00) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7951896 1.00 ALDH1A1 (1.00) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7963720 0.86 HPGD (0.76) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7963723 0.86 HPGD (0.76) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7963726 0.86 HPGD (0.76) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7952227 0.84 ALDH1A1 (0.73) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7952230 0.84 ALDH1A1 (0.73) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL7952229 0.84 ALDH1A1 (0.73) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL4419297 0.84 KDM4E (0.72) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL1248024 0.84 PKM (0.76) ALDH1A1HPGDKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed